Search

Your search keyword '"Amanda L. Posgai"' showing total 33 results

Search Constraints

Start Over You searched for: Author "Amanda L. Posgai" Remove constraint Author: "Amanda L. Posgai" Topic medicine.disease Remove constraint Topic: medicine.disease
33 results on '"Amanda L. Posgai"'

Search Results

1. The Women’s Leadership Gap in Diabetes: A Call for Equity and Excellence

2. Image-Based Machine Learning Algorithms for Disease Characterization in the Human Type 1 Diabetes Pancreas

3. How Do We Move Type 1 Diabetes Immunotherapies Forward During the Current COVID-19 Pandemic?

4. Low-Dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report

5. Exocrine Pancreatic Enzymes Are a Serological Biomarker for Type 1 Diabetes Staging and Pancreas Size

6. Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes

7. Temporal Analysis of Amylase Expression in Control, Autoantibody-Positive, and Type 1 Diabetes Pancreatic Tissues

8. Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis

9. ACE2 and SARS-CoV-2 Expression in the Normal and COVID-19 Pancreas

10. CD226 Deletion Reduces Type 1 Diabetes in the NOD Mouse by Impairing Thymocyte Development and Peripheral T Cell Activation

11. Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes

12. Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic β cells

13. ACE2 and SARS-CoV-2 Expression in the Normal and COVID-19 Pancreas

14. Insulin-Like Growth Factor Dysregulation Both Preceding and Following Type 1 Diabetes Diagnosis

15. 1366-P: Effect of Substance Use on Type 1 Diabetes (T1D) Pancreas Histopathology

16. The challenge of modulating beta-cell autoimmunity in type 1 diabetes

17. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus

18. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19

19. Immune Mechanisms and Pathways Targeted in Type 1 Diabetes

20. Exocrine Pancreatic Function as a Novel Biomarker in Pre-T1D

21. Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling

22. A Preclinical Consortium Approach for Assessing the Efficacy of Combined Anti-CD3 Plus IL-1 Blockade in Reversing New-Onset Autoimmune Diabetes in NOD Mice

23. Mobilization without immune depletion fails to restore immunological tolerance or preserve beta cell function in recent onset type 1 diabetes

24. Acute Versus Progressive Onset of Diabetes in NOD Mice: Potential Implications for Therapeutic Interventions in Type 1 Diabetes

25. Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes

26. Diagnostic Dilemma: Clinical and Histological Abnormalities in a Hispanic Patient With Diabetes

27. Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes

28. Serum Trypsinogen Levels in Type 1 Diabetes

29. Raising Awareness: The Need to Promote Allocation of Pancreata From Rare Nondiabetic Donors With Pancreatic Islet Autoimmunity to Type 1 Diabetes Research

30. Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice

31. Response to Comment on Jackson et al. Insulitis in Autoantibody-Positive Pancreatic Donor With History of Gestational Diabetes Mellitus. Diabetes Care 2017;40:723–725

32. Persistence of Pancreatic Insulin mRNA Expression and Proinsulin Protein in Type 1 Diabetes Pancreata

33. Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice

Catalog

Books, media, physical & digital resources